CNTA
Centessa Pharmaceuticals PLC ADRNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$6.15B
P/E Ratio
—
EPS
$-1.46
Beta
1.26
52W High
$40.26
52W Low
$10.95
50-Day MA
$27.22
200-Day MA
$22.72
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Centessa Pharmaceuticals PLC ADR
Centessa Pharmaceuticals Limited, a pharmaceutical company, develops and delivers drugs that change and improve the lives of patients. The company is headquartered in Cambridge, the United Kingdom.
Fundamentals
| Revenue (TTM) | $15.00M |
| Gross Profit (TTM) | $15.00M |
| EBITDA | $-207.37M |
| Operating Margin | -1385.00% |
| Return on Equity | -42.50% |
| Return on Assets | -20.50% |
| Revenue/Share (TTM) | $0.11 |
| Book Value | $3.53 |
| Price-to-Book | 11.65 |
| Price-to-Sales (TTM) | 409.96 |
| EV/Revenue | 397.49 |
| EV/EBITDA | 1.12 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $154.66M |
| Float | $97.86M |
| % Insiders | 0.47% |
| % Institutions | 96.10% |
Historical Volatility
HV 10-Day
187.01%
HV 20-Day
140.40%
HV 30-Day
115.82%
HV 60-Day
85.60%
HV Rank
98.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($43.57 target)
1
Strong Buy8
Buy4
HoldData last updated: 4/10/2026